FDA clears exoskeleton for stroke rehabilitation

Поділитися
Вставка
  • Опубліковано 22 січ 2023
  • The U.S. Food and Drug Administration has cleared Wandercraft's self-balancing exoskeleton for use in stroke rehabilitation. In July 2021, Reuters was given a first-hand demonstration of the possibilities wearable exoskeletons can have for people with disabilities.
    #Exoskeleton #Rehab #Wandercraft #FDA #Science #Technology #News #Reuters #newsfeed
    Subscribe: smarturl.it/reuterssubscribe
    Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
    Get the latest news on: www.reuters.com/
    Follow Reuters on Facebook: / reuters
    Follow Reuters on Twitter: / reuters
    Follow Reuters on Instagram: reuters?hl=en
  • Наука та технологія

КОМЕНТАРІ •